Using PET and MRI to predict recurrence probability in glioblastoma patients could allow increased radiotherapy dose delivery to high-risk tumour regions
The MetaboliQs consortium will combine quantum sensing and medical imaging for precision diagnostics and personalized treatment of cardiovascular diseases